97106183 - EXOTAC

Information

• Trademark
• 97106183

• Source

• Serial Number

  97106183

• Registration Number

  7459469

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 03, 2021
  3 years ago

• Registration Date

  July 30, 2024
  5 months ago

• Transaction Date

  July 30, 2024
  5 months ago

• Status Date

  July 30, 2024
  5 months ago

• Published for Opposition Date

  May 14, 2024
  8 months ago

• Location Date

  July 29, 2024
  5 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  DWYER, JOHN D

• Attorney Docket Number

  TK0172336

  Attorney Name

  Jae Youn Kim

• Owners

  • ILIAS BIOLOGICS INC

Case File Statements

• GS0051: Biological preparations for medical or veterinary purposes for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; biochemical preparations for medical or veterinary purposes for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceuticals featuring drug delivery system, namely, pharmaceutical preparations for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, urinary diseases; preparations for intracellular drug delivery, namely, drug delivery agents in the form of capsules, tablets, pills, powders, liquids, suspensions, injections, creams, emulsions, gels, liniments, lotions, ointments, pathes, solutions, syrups, aerosols, granules, implants, inhalants, pellets that facilitate the delivery of pharmaceutical preparations; pharmaceuticals for the treatment of immune system disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of cellular diseases; chemico-pharmaceutical preparations for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; protein preparations, namely, protein supplements; biotechnological preparations for medical purposes for treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; reagents for medical use; pharmaceuticals for human purposes for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; biochemical pharmaceuticals for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases; biological tissue cultures for medical purposes; diagnostic reagents for medical use; pharmaceuticals for the treatment of cancer, metabolic diseases, inflammatory diseases, genetic diseases, infectious diseases, cardiovascular diseases, respiratory diseases, neurological diseases, auto-immune diseases, fibrosis diseases, allergies, skin diseases, endocrine diseases, gastrointestinal diseases, hematologic diseases, diseases and disorders of the immune system, ophthalmic diseases, kidney diseases, and urinary diseases
• GS0011: Biological preparations, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological preparation for use in the manufacture of pharmaceuticals; biological preparations for use in experiments containing exosomes carrying the desired protein, other than for medical or veterinary use; biochemical preparations for gene recombination for scientific or laboratory purposes; biological tissue cultures, other than for medical or veterinary purposes; cells for scientific or laboratory purposes; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents for use in biological or genetic engineering for scientific or research use and medical laboratory use; reagents for scientific or medical research use; biological preparations for use in biotechnology industry and science, other than for medical purpose; cell growth media for growing cells for use in scientific research; biochemicals for in vitro and in vivo scientific use; reagents for medical research; biological preparation containingexosomes for use in manufacture of cosmetics; protein for use in the manufacture of cosmetics; chemical preparations for use in the manufacture of cosmetics; chemical additives for use in the manufacture of cosmetics; proteins for the food industry
• GS0421: Research and development of technology for biotechnology; development of pharmaceutical preparations and medicines; development of cell therapy products; research and development of new pharmaceuticals; medical research and product development services; research and development of vaccines and medicines; product development in the field of biologics; research of biologics, namely, scientific study and research in the field of biologics; laboratory research in the field of biology; industrial research in the field of biomedical engineering; technological research in the field of cell biology; scientific research in the field of pharmaceuticals; biotechnology research; biological research services; research for medical products; research in the field of chemistry; drug discovery services; biomedical research services; pharmaceutical drug development services

Case File Event Statements

• 11/6/2021 - 3 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/13/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/13/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/21/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/21/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 8/21/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 2/18/2023 - a year ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/18/2023 - a year ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/20/2023 - a year ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/14/2023 - a year ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 3/14/2023 - a year ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL

• 3/14/2023 - a year ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 9/11/2023 - a year ago

  13 - SUSPENSION INQUIRY WRITTEN Type: CNSI

• 9/11/2023 - a year ago

  14 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI

• 9/11/2023 - a year ago

  15 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2

• 11/18/2023 - a year ago

  16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI

• 4/9/2024 - 9 months ago

  17 - ASSIGNED TO LIE Type: ALIE

• 4/11/2024 - 9 months ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/11/2024 - 9 months ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/11/2024 - 9 months ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/24/2024 - 9 months ago

  21 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/14/2024 - 8 months ago

  22 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/14/2024 - 8 months ago

  23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 7/30/2024 - 5 months ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 7/30/2024 - 5 months ago

  25 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC